Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone

William H. Hoffman, Frank Kappler, Gregory G. Passmore, Renuka Mehta

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objectives: Highly reactive dicarbonyl compounds are known to be increased by hyperglycemia, ketone bodies and lipid peroxidation. This study was carried out to investigate the effect of diabetic ketoacidosis (DKA) and its treatment on the plasma concentration of 3 deoxyglucosone (3-DG) one of the dicarbonyl compounds. Design and Methods: 3-DG was measured in 7 children before, during and following correction of severe DKA. Results: 3-DG was elevated before treatment (610 nmol/L ± 70) in comparison to baseline (120 h) (200 nmol/L ± 17) (p < 0.05). At 6 to 24 h into treatment 3-DG was further elevated (1,080 nmol/L ± 80) in comparison to both pretreatment (p < 0.05) and baseline (p < 0.05). Conclusion: 3-DG is significantly elevated before the treatment of DKA and increases further during the treatment of DKA. The time course of the increase of 3-DG coincides with the time of progression of subclinical brain edema, which occurs in DKA.

Original languageEnglish (US)
Pages (from-to)269-273
Number of pages5
JournalClinical Biochemistry
Volume36
Issue number4
DOIs
StatePublished - Jun 2003

Fingerprint

Diabetic Ketoacidosis
Plasmas
Therapeutics
Ketone Bodies
Brain Edema
Hyperglycemia
Lipid Peroxidation
3-deoxyglucosone
Brain
Lipids

Keywords

  • 3 Deoxyglucosone
  • Carbonyl stress
  • Diabetic complications
  • Diabetic ketoacidosis
  • Oxidative stress

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone. / Hoffman, William H.; Kappler, Frank; Passmore, Gregory G.; Mehta, Renuka.

In: Clinical Biochemistry, Vol. 36, No. 4, 06.2003, p. 269-273.

Research output: Contribution to journalArticle

@article{426f92a5c0654eb6828a407939719dd5,
title = "Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone",
abstract = "Objectives: Highly reactive dicarbonyl compounds are known to be increased by hyperglycemia, ketone bodies and lipid peroxidation. This study was carried out to investigate the effect of diabetic ketoacidosis (DKA) and its treatment on the plasma concentration of 3 deoxyglucosone (3-DG) one of the dicarbonyl compounds. Design and Methods: 3-DG was measured in 7 children before, during and following correction of severe DKA. Results: 3-DG was elevated before treatment (610 nmol/L ± 70) in comparison to baseline (120 h) (200 nmol/L ± 17) (p < 0.05). At 6 to 24 h into treatment 3-DG was further elevated (1,080 nmol/L ± 80) in comparison to both pretreatment (p < 0.05) and baseline (p < 0.05). Conclusion: 3-DG is significantly elevated before the treatment of DKA and increases further during the treatment of DKA. The time course of the increase of 3-DG coincides with the time of progression of subclinical brain edema, which occurs in DKA.",
keywords = "3 Deoxyglucosone, Carbonyl stress, Diabetic complications, Diabetic ketoacidosis, Oxidative stress",
author = "Hoffman, {William H.} and Frank Kappler and Passmore, {Gregory G.} and Renuka Mehta",
year = "2003",
month = "6",
doi = "10.1016/S0009-9120(03)00030-4",
language = "English (US)",
volume = "36",
pages = "269--273",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Diabetic ketoacidosis and its treatment increase plasma 3-deoxyglucosone

AU - Hoffman, William H.

AU - Kappler, Frank

AU - Passmore, Gregory G.

AU - Mehta, Renuka

PY - 2003/6

Y1 - 2003/6

N2 - Objectives: Highly reactive dicarbonyl compounds are known to be increased by hyperglycemia, ketone bodies and lipid peroxidation. This study was carried out to investigate the effect of diabetic ketoacidosis (DKA) and its treatment on the plasma concentration of 3 deoxyglucosone (3-DG) one of the dicarbonyl compounds. Design and Methods: 3-DG was measured in 7 children before, during and following correction of severe DKA. Results: 3-DG was elevated before treatment (610 nmol/L ± 70) in comparison to baseline (120 h) (200 nmol/L ± 17) (p < 0.05). At 6 to 24 h into treatment 3-DG was further elevated (1,080 nmol/L ± 80) in comparison to both pretreatment (p < 0.05) and baseline (p < 0.05). Conclusion: 3-DG is significantly elevated before the treatment of DKA and increases further during the treatment of DKA. The time course of the increase of 3-DG coincides with the time of progression of subclinical brain edema, which occurs in DKA.

AB - Objectives: Highly reactive dicarbonyl compounds are known to be increased by hyperglycemia, ketone bodies and lipid peroxidation. This study was carried out to investigate the effect of diabetic ketoacidosis (DKA) and its treatment on the plasma concentration of 3 deoxyglucosone (3-DG) one of the dicarbonyl compounds. Design and Methods: 3-DG was measured in 7 children before, during and following correction of severe DKA. Results: 3-DG was elevated before treatment (610 nmol/L ± 70) in comparison to baseline (120 h) (200 nmol/L ± 17) (p < 0.05). At 6 to 24 h into treatment 3-DG was further elevated (1,080 nmol/L ± 80) in comparison to both pretreatment (p < 0.05) and baseline (p < 0.05). Conclusion: 3-DG is significantly elevated before the treatment of DKA and increases further during the treatment of DKA. The time course of the increase of 3-DG coincides with the time of progression of subclinical brain edema, which occurs in DKA.

KW - 3 Deoxyglucosone

KW - Carbonyl stress

KW - Diabetic complications

KW - Diabetic ketoacidosis

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=0038179143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038179143&partnerID=8YFLogxK

U2 - 10.1016/S0009-9120(03)00030-4

DO - 10.1016/S0009-9120(03)00030-4

M3 - Article

C2 - 12810155

AN - SCOPUS:0038179143

VL - 36

SP - 269

EP - 273

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 4

ER -